News
17d
India Today on MSNBharat Biotech and GSK cut price of world's first malaria vaccine to under $5Bharat Biotech and GSK announce price reduction for the world's first malaria vaccine to under $5. This move aims to improve access and save thousands of children in malaria-endemic countries.
Bharat Biotech International Ltd and GSK plc on Wednesday said they will reduce the price of the world's first malaria vaccine for children 'RTS,S' developed by GSK, PATH and partners, by more than ...
HYDERABAD: Vaccine maker Bharat Biotech International Ltd and British biopharma giant GSK plc will be slashing the prices of the world’s first malaria vaccine – RTS,S or Mosquirix – by over half to ...
Bharat Biotech, an established supplier to global vaccine alliance Gavi, quickly signed on to help with antigen manufacturing in a product transfer agreement meant to boost the long-term supply of ...
India's Bharat Biotech said on Tuesday its oral cholera vaccine cleared a late-stage trial and that it plans a global launch, aiming to make up to 200 million doses a year amid an expanding ...
Emails between Bharat Biotech and the ministry submitted to CPI showed an initial quoted price of $1.34 per dose, which later rose to $15 per dose in the negotiated contract, according to a CPI ...
Item 1 of 2 Rupali Deshraj Nirmal, 16, reacts as she receives a dose of Bharat Biotech's COVID-19 vaccine, Covaxin, during a vaccination drive for children aged 15-18 in Mumbai, India, January 3 ...
Deficiencies found (WHO) suspended the supply of Bharat Biotech's Covaxin vaccine under the United Nations procurement after an inspection last month.
Bharat Biotech’s Mohan, however, maintained that the company felt confident proceeding to Phase 3 as it did, given results in animal testing, and that the decision to settle on dosing was ...
Bharat Biotech is pumping $75 million into a new cell and therapy manufacturing facility at the Indian drugmaker’s facility located in what is known as Genome Vally in Hyderabad.
In a recent development, Bharat Biotech and GSK announced a price reduction of $5, which aims to improve access and save thousands of children who suffer from malaria.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results